Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

A novel DNA-binding motif in Prostate Tumor Overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.

PMID: 30922918
Journal: CANCER LETTERS
Year: 2019
Reference: Cancer Lett. 2019 Jun 28;452:158-167. doi: 10.1016/j.canlet.2019.03.019. Epub 2019 Mar 25.
Impact factor: 6.508
Publication type: Paper in international publication
Authors: Paciucci, Rosanna, Ciudad, Carlos J, Noe, Veronique, Morote, Juan, Maggio, Valentina, Canovas, Veronica, Felix, Alex J, Gomez, Valenti, de Torres, Ines, Semidey, Maria Eugenia et al.
DOI: 10.1016/j.canlet.2019.03.019

A novel DNA-binding motif in Prostate Tumor Overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.

PMID: 30922918
Journal: CANCER LETTERS
Year: 2019
Reference: Cancer Lett. 2019 Jun 28;452:158-167. doi: 10.1016/j.canlet.2019.03.019. Epub 2019 Mar 25.
Impact factor:
Publication type: Paper in international publication
Authors: Canovas, Veronica; Ciudad, Carlos J; de Torres, Ines; Felix, Alex J; Gomez, Valenti; Maggio, Valentina; Morote, Juan; Noe, Veronique; Paciucci, Rosanna; Semidey, Maria Eugenia et al.
DOI: 10.1016/j.canlet.2019.03.019

A Novel Homozygous AMRH2 Gene Mutation in a Patient with Persistent Mullerian Duct Syndrome.

PMID: 30933950
Journal: Sexual Development
Year: 2019
Reference: Sex Dev. 2019;13(2):87-91. doi: 10.1159/000499324. Epub 2019 Apr 2.
Impact factor: 2.25
Publication type: Paper in international publication
Authors: Fernandez-Cancio, Monica, Viswanath, Naveen, Puzhankara, Ramakrishnan, Valiyaprambil Pavithran, Praveen, Mora-Palma, Cristina, Camats, Nuria, Audi, Laura, Benito-Sanz, Sara et al.
DOI: 10.1159/000499324

A Novel Homozygous AMRH2 Gene Mutation in a Patient with Persistent Mullerian Duct Syndrome.

PMID: 30933950
Journal: Sexual Development
Year: 2019
Reference: Sex Dev. 2019;13(2):87-91. doi: 10.1159/000499324. Epub 2019 Apr 2.
Impact factor:
Publication type: Paper in international publication
Authors: Audi, Laura; Benito-Sanz, Sara; Camats, Nuria; Fernandez-Cancio, Monica; Mora-Palma, Cristina; Puzhankara, Ramakrishnan; Valiyaprambil Pavithran, Praveen; Viswanath, Naveen et al.
DOI: 10.1159/000499324

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.

PMID: 31757017
Journal: Journal of Clinical Medicine
Year: 2019
Reference: J Clin Med. 2019 Nov 20;8(12). pii: jcm8122029. doi: 10.3390/jcm8122029.
Impact factor: 5.688
Publication type: Paper in international publication
Authors: Rapado-Gonzalez, Oscar, Majem, Blanca, Alvarez-Castro, Ana, Diaz-Pena, Roberto, Abalo, Alicia, Suarez-Cabrera, Leticia, Gil-Moreno, Antonio, Santamaria, Anna, Lopez-Lopez, Rafael, Suarez-Cunqueiro, Maria Mercedes et al.
DOI: 10.3390/jcm8122029

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.

PMID: 31757017
Journal: Journal of Clinical Medicine
Year: 2019
Reference: J Clin Med. 2019 Nov 20;8(12). pii: jcm8122029. doi: 10.3390/jcm8122029.
Impact factor:
Publication type: Paper in international publication
Authors: Abalo, Alicia; Alvarez-Castro, Ana; Diaz-Pena, Roberto; Gil-Moreno, Antonio; Lopez-Lopez, Rafael; Majem, Blanca; Muinelo-Romay, Laura; Rapado-Gonzalez, Oscar; Santamaria, Anna; Suarez-Cabrera, Leticia et al.
DOI: 10.3390/jcm8122029

A phase 1/2, open-label, dose-expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer.

PMID: 32085008
Journal: ANNALS OF ONCOLOGY
Year: 2019
Reference: Ann Oncol. 2019 Jul;30 Suppl 4:iv123. doi: 10.1093/annonc/mdz157.004. Epub 2019 Dec 4.
Impact factor: 14.196
Publication type: Letter or abstract
Authors: Wainberg, Z, Boland, P, Lieu, C, Dayyani, F, Macarulla, T, Zhang, B, Belanger, B, Moore, Y, Wang, T, Maxwell, F et al.
DOI: 10.1093/annonc/mdz157.004

A phase 1/2, open-label, dose-expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer.

PMID: 32085008
Journal: ANNALS OF ONCOLOGY
Year: 2019
Reference: Ann Oncol. 2019 Jul;30 Suppl 4:iv123. doi: 10.1093/annonc/mdz157.004. Epub 2019 Dec 4.
Impact factor:
Publication type: Letter or abstract
Authors: Belanger, B; Boland, P; Dayyani, F; Dean, A; Lieu, C; Macarulla, T; Maxwell, F; Moore, Y; Wainberg, Z; Wang, T et al.
DOI: 10.1093/annonc/mdz157.004

A phase 2 randomised study of veliparib plus FOLFIRI+/-bevacizumab versus placebo plus FOLFIRI+/-bevacizumab in metastatic colorectal cancer.

PMID: 30531832
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Jan;120(2):183-189. doi: 10.1038/s41416-018-0343-z. Epub 2018 Dec 11.
Impact factor: 5.416
Publication type: Paper in international publication
Authors: Deming, Dustin A, Ramanathan, Ramesh K, Torres, Alison H, Sullivan, Danielle, Luo, Yan, Berlin, Jordan D, Elez Fernandez, Elena, Mangel, Laszlo, Cubillo Gracian, Antonio, Nechaeva, Marina et al.
DOI: 10.1038/s41416-018-0343-z

A phase 2 randomised study of veliparib plus FOLFIRI+/-bevacizumab versus placebo plus FOLFIRI+/-bevacizumab in metastatic colorectal cancer.

PMID: 30531832
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Jan;120(2):183-189. doi: 10.1038/s41416-018-0343-z. Epub 2018 Dec 11.
Impact factor:
Publication type: Paper in international publication
Authors: Beck, J Thaddeus; Berlin, Jordan D; Cubillo Gracian, Antonio; Deming, Dustin A; Elez Fernandez, Elena; Garcia-Alfonso, Pilar; Gorbunova, Vera; Hofheinz, Ralf-Dieter; Luo, Yan; Mangel, Laszlo et al.
DOI: 10.1038/s41416-018-0343-z

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.

PMID: 31363167
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Aug;121(5):378-383. doi: 10.1038/s41416-019-0537-z. Epub 2019 Jul 31.
Impact factor: 5.416
Publication type: Paper in international publication
Authors: Safont, Maria Jose, Gallego, Javier, Gravalos, Cristina, Arrivi, Antonio, Carrato, Alfredo, Conde, Veronica, Ortiz, Maria Jose, Lopez, Carlos, Alonso, Beatriz, Ruiz de Mena, Inmaculada et al.
DOI: 10.1038/s41416-019-0537-z

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.

PMID: 31363167
Journal: BRITISH JOURNAL OF CANCER
Year: 2019
Reference: Br J Cancer. 2019 Aug;121(5):378-383. doi: 10.1038/s41416-019-0537-z. Epub 2019 Jul 31.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso, Beatriz; Aranda, Enrique; Arrivi, Antonio; Bando, Inmaculada; Carrato, Alfredo; Conde, Veronica; Diaz-Rubio, Eduardo; Elez, Elena; Gallego, Javier; Gravalos, Cristina et al.
DOI: 10.1038/s41416-019-0537-z

A Phase I, Multicenter, Dose-Escalation Study of the Oral Selective FGFR inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations.

PMID: 30745300
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2699-2707. doi: 10.1158/1078-0432.CCR-18-1959. Epub 2019 Feb 11.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Voss, Martin H, Cleary, James M, Meric-Bernstam, Funda, Tabernero, Josep, Janku, Filip, Gandhi, Leena, Iafrate, A John, Borger, Darrell R, Ishii, Nobuya, Hu, Youyou et al.
DOI: 10.1158/1078-0432.CCR-18-1959

A Phase I, Multicenter, Dose-Escalation Study of the Oral Selective FGFR inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations.

PMID: 30745300
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2699-2707. doi: 10.1158/1078-0432.CCR-18-1959. Epub 2019 Feb 11.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, Jose; Borger, Darrell R; Cleary, James M; Flaherty, Keith T; Gandhi, Leena; Heist, Rebecca S; Hierro, Cinta; Hu, Youyou; Iafrate, A John; Ishii, Nobuya et al.
DOI: 10.1158/1078-0432.CCR-18-1959

A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer.

PMID: 31368034
Journal: BREAST CANCER RESEARCH AND TREATMENT
Year: 2019
Reference: Breast Cancer Res Treat. 2019 Nov;178(1):121-133. doi: 10.1007/s10549-019-05360-3. Epub 2019 Jul 31.
Impact factor: 3.471
Publication type: Paper in international publication
Authors: Reyner, Eric, Bond, John, Cui, Na, Wilson, Timothy R, Moore, Heather M, Saura, Cristina, Krop, Ian E, Wei, Michael C, Richey, Stephen, Becerra, Carlos et al.
DOI: 10.1007/s10549-019-05360-3

A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer.

PMID: 31368034
Journal: BREAST CANCER RESEARCH AND TREATMENT
Year: 2019
Reference: Breast Cancer Res Treat. 2019 Nov;178(1):121-133. doi: 10.1007/s10549-019-05360-3. Epub 2019 Jul 31.
Impact factor:
Publication type: Paper in international publication
Authors: Abramson, Vandana G; Bauer, Todd M; Becerra, Carlos; Bedard, Philippe L; Bond, John; Cervantes, Andres; Cui, Na; Krop, Ian E; Moore, Heather M; Oliveira, Mafalda et al.
DOI: 10.1007/s10549-019-05360-3

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer.

PMID: 31423336
Journal: ESMO Open
Year: 2019
Reference: ESMO Open. 2019 Jul 22;4(4):e000532. doi: 10.1136/esmoopen-2019-000532. eCollection 2019.
Impact factor: 0
Publication type: Paper in international publication
Authors: Cervantes, Andres, Weisser, Martin, Hasmann, Max, Ceppi, Maurizio, James, Ian, Cejalvo, Juan-Miguel, Fleitas Kanonnikoff, Tania, Felip, Enriqueta, Navarro Mendivil, Alejandro, Martinez Garcia, Maria et al.
DOI: 10.1136/esmoopen-2019-000532

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer.

PMID: 31423336
Journal: ESMO open
Year: 2019
Reference: ESMO Open. 2019 Jul 22;4(4):e000532. doi: 10.1136/esmoopen-2019-000532. eCollection 2019.
Impact factor:
Publication type: Paper in international publication
Authors: Adessi, Celine; Cejalvo, Juan-Miguel; Ceppi, Maurizio; Cervantes, Andres; Felip, Enriqueta; Fleitas Kanonnikoff, Tania; Hasmann, Max; Jacob, Wolfgang; James, Ian; Lassen, Ulrik et al.
DOI: 10.1136/esmoopen-2019-000532

A Phase II Study of Talazoparib After Platinum or Cytotoxic Nonplatinum Regimens in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO).

PMID: 30563931
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2717-2724. doi: 10.1158/1078-0432.CCR-18-1891. Epub 2018 Dec 18.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Turner, Nicholas C, Telli, Melinda L, Rugo, Hope S, Mailliez, Audrey, Ettl, Johannes, Grischke, Eva-Maria, Mina, Lida A, Balmana, Judith, Fasching, Peter A, Hurvitz, Sara A et al.
DOI: 10.1158/1078-0432.CCR-18-1891

A Phase II Study of Talazoparib After Platinum or Cytotoxic Nonplatinum Regimens in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO).

PMID: 30563931
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 May 1;25(9):2717-2724. doi: 10.1158/1078-0432.CCR-18-1891. Epub 2018 Dec 18.
Impact factor:
Publication type: Paper in international publication
Authors: Balmana, Judith; Chappey, Colombe; Ettl, Johannes; Fasching, Peter A; Grischke, Eva-Maria; Hannah, Alison L; Hurvitz, Sara A; Mailliez, Audrey; Mina, Lida A; Robson, Mark E et al.
DOI: 10.1158/1078-0432.CCR-18-1891

A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms.

PMID: 30659475
Journal: BEHAVIOR GENETICS
Year: 2019
Reference: Behav Genet. 2019 May;49(3):270-285. doi: 10.1007/s10519-018-09947-2. Epub 2019 Jan 18.
Impact factor: 2.313
Publication type: Paper in international publication
Authors: Kiemeney, L A, Arias-Vasquez, A, Groffen, A J, Spijker, S, Ouwens, K G, Klein, M, Vojinovic, D, Galesloot, T E, Bralten, J, Hottenga, J J et al.
DOI: 10.1007/s10519-018-09947-2

A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms.

PMID: 30659475
Journal: BEHAVIOR GENETICS
Year: 2019
Reference: Behav Genet. 2019 May;49(3):270-285. doi: 10.1007/s10519-018-09947-2. Epub 2019 Jan 18.
Impact factor:
Publication type: Paper in international publication
Authors: Amin, N; Arias-Vasquez, A; Boomsma, D I; Bralten, J; Buitelaar, J K; den Braber, A; Dolan, C V; Draisma, H H M; Fedko, I O; Franke, B et al.
DOI: 10.1007/s10519-018-09947-2

A propensity score-matched analysis of laparoscopic versus open surgery for rectal cancer in a population-based study.

PMID: 30585686
Journal: Colorectal Disease
Year: 2019
Reference: Colorectal Dis. 2019 Apr;21(4):441-450. doi: 10.1111/codi.14545. Epub 2019 Jan 17.
Impact factor: 2.997
Publication type: Paper in international publication
Authors: Borras, Josep M, Manchon-Walsh, Paula, Aliste, Luisa, Biondo, Sebastiano, Espin, Eloy, Pera, Miguel, Targarona, Eduard, Pallares, Natalia, Vernet, Raul R, Espinas, Josep A et al.
DOI: 10.1111/codi.14545

A propensity score-matched analysis of laparoscopic versus open surgery for rectal cancer in a population-based study.

PMID: 30585686
Journal: Colorectal Disease
Year: 2019
Reference: Colorectal Dis. 2019 Apr;21(4):441-450. doi: 10.1111/codi.14545. Epub 2019 Jan 17.
Impact factor:
Publication type: Paper in international publication
Authors: Aliste, Luisa; Biondo, Sebastiano; Borras, Josep M; Espin, Eloy; Espinas, Josep A; Guarga, Alex; Manchon-Walsh, Paula; Pallares, Natalia; Pera, Miguel; Targarona, Eduard et al.
DOI: 10.1111/codi.14545